CASTLE BIOSCIENCES, INC. (CSTL) Return on equity 2019–2025
CASTLE BIOSCIENCES, INC. (CSTL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-5.1%FY2025 · since FY2019: 6.2% → -5.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.1% | -9.1 pp |
| FY2024 | 4.0% | +18.7 pp |
| FY2023 | -14.7% | +2.1 pp |
| FY2022 | -16.8% | -9.2 pp |
| FY2021 | -7.6% | -5.1 pp |
| FY2020 | -2.5% | -8.7 pp |
| FY2019 | 6.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating marginCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →